Technology Transfer / Patents & Licensing
USF Start-up Companies
At the Office of Technology Transfer, one of our primary goals is to foster the growth of new businesses based on University of South Florida research. We work with inventors, entrepreneurs, and investors to create successful transitions from innovation to new enterprise.
AbleNook is a rapidly deployable portable structure comprised of interlocking components which can be assembled by unskilled laborers in a short period of time (without tools). These components are shipped flat-packed in order to maximize the number of families who are helped in disaster areas, while reducing transportation costs.
Agilis Biotherapeutics is advancing innovative DNA therapeutics designed to provide long-term efficacy for patients with debilitating, often fatal, rare genetic diseases that affect the central nervous system.
Apollo Medical Devices is commercializing a rapid blood testing technology with an anticipated turnaround time of five minutes using just a single drop of blood. According to the National Library of Medicine, blood chemistry tests are the most frequently ordered tests by physicians in the United States with a typical turnaround time ranging anywhere from 30 minutes to 2 hours. Point-of-care blood chemistry testing can reduce this turnaround time to enable faster diagnosis and decision-making, with the overarching goal of better patient care.
Aqua Membranes provides innovative technology development,
product commercialization, and consulting to serve the water needs of mankind.
BioReNEW Inc. is a CleanTech startup dedicated to addressing global grand challenges in water, energy, food and sanitation by accelerating nature in a compact bioengineered platform. The company's patented NEWgenerator technology generates nutrients, energy, and water by safely recovering them from wastewater.
Cahaba Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of clinical stage drug therapies targeting both the molecular basis of cancer and side effects of cancer treatment.
Cheetah Data Systems Inc. is a startup that specializes in novel software for databases, used extensively in everyday computing (e.g. internet searches), which fully takes advantage of modern Graphics Processing Units (GPUs). Their technology shows and 10x improvement database queries compared to current CPU programs and up to 14x improvement over known GPU algorithms.
ClearSpec LLC, a division of MDI Worldwide, is the developer of a new, patented and FDA cleared device, which is scientifically proven by an IRB randomized clinical study to improve visualization of the cervix for every exam. ClearSpec addresses many of the problems associated with proper visualization, diagnosis and treatment of cervical disease, improving patient outcomes for women worldwide.
CvergenX, Inc. is an early stage advanced diagnostic services company that was founded to provide personalized medicine tools for the field of radiation oncology. The Company's Intervene XRT testing platform applies genomic analysis to predict a tumor's response to radiation and to assist the oncologist in determining the optimal level of radiation dosing. CvergenX joins a growing group of personalized medicine companies that are applying genomics-basis analysis to clinical practice to enable a more personalized and accurate approach to patient care.
By advancing novel approaches that target whole body metabolism, our mission at Disruptive Nutrition is to provide high quality nutrition products backed by scientific evidence to support health and wellness. Disruptive Nutrition develops products formulated to not only promote health, but also boost the body's own ability to combat disease in rare genetic disorders. We strive to work with researchers at the cutting edge of truly disruptive innovation, and then design products that meet the unique needs and qualities of the patient.
Gratitude Health, Inc. is dedicated to creating and delivering first-to-market, innovative and certified-organic beverages to consumers as an alternative to sugar-laden, chemically treated, harmful drinks. The Company manufactures, sells and markets functional RTD (Ready to drink) beverages sold under the Gratitude trademark.
Hemolix, LLC is a startup focused on the early detection of dangerous pregnancy complications using a mobile phone based platform called Hemolix.
IBIS Therapeutics, LLC is a company committed to providing innovative healthcare services. IBIS offers a range of health technologies, including biotech sensor systems, pathogen detection and identification services.
Moving to St. Petersburg
IRX Therapeutics is focused on making cancer treatments better. IRX develops immune therapies designed to activate a patient's immune system to defeat cancer and related diseases.
KeriCure Inc is a medical device company that specializes in research and development of topical products with a focus on wound care.
Ketone Technologies, LLC partners with private and government agencies to advance the science and application of nutritional ketosis as a metabolic-based therapy and for enhancing safety, performance, and resilience of military personnel.
Lawbec Innovations, LLC is a company dedicated to developing mobile health innovations and technology. These advancements are directed to benefit and improve the health of patients with chronic diseases.
Looshes Labs Skate, LLC has designed and created a skateboard and longboard with built in storage. Items such as tablet computers, smart phones, wallet, keys, and any other personal accessories fit easily and safely inside. Each board is handmade and must pass through several stages of quality control. Looshes Labs is the only company that has been licensed this technology for manufacturing and distribution.
MegaNano BioTech's purpose is to develop best immunotherapies for neurodegenerative disease and cancers including vaccine, antibodies. Our services are antigen identification, ELISA kit development, diagnostic antibodies development.
MiMedx Group is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products. The company is committed to the commercialization of Biomaterials that improve surgical outcomes by solving an unmet or underserved clinical need.
Modelithics is the premier provider of high-precision measurements and models for microwave/RF design simulation. They have the experience, equipment, and knowledge to accurately measure components and build software models that enable popular circuit simulation tools to generate more accurate predictions of as-built performance. Simply put, you will move from concept to product faster with Modelilthics models
Modulation Therapeutics is an early stage biotech company dedicated to the cost-effective advancement of first in class molecules to improve patient outcomes in unmet medical needs such as relapsed multiple myeloma and AML two hematopoietic tumors characterized by homing to the bone marrow and solid tumors that metastasize to the bone including lung, breast and prostate.
Moterum, Inc. - The gait enhancing mobile shoe (GEMS) alters the wearer's gait by causing one foot
to move backward during the stance phase while walking over ground. No external power
is required since the shoe mechanically converts the wearer's downward and horizontal
forces into a backward motion. This shoe allows a patient to walk over ground while
experiencing the same gait altering effects as felt on a split-belt treadmill, which
should aid in transferring the corrected gait to walking in natural environments.
Natura Therapeutics, Inc. is a science-based company committed to providing high quality nutritional products researched and developed by its team of leading experts in the fields of nutritional science and stem cell research.
The company focuses on medical devices, namely, transcranial electromagnetic treatment devices. The primary goal of NeuroEM Therapeutics is to clinically test and market TEMT as an effective prevention and treatment against Alzheimer's disease.
Ovation Diagnostics LLC is dedicated to developing advanced and accessible ovarian cancer diagnostic technologies to address a global unmet need.
Phoinix Holding, LLC commercializes patented breakthrough healthcare/life science technologies developed by USF research scientists that make life easier and better for all living things.
Prescient Therapeutics (PTX) is a clinical stage oncology company developing novel compounds that show great promise as potential new therapies to treat a range of solid and hematological cancers. The Company's novel compounds inhibit key tumor survival pathways, inhibiting cancer growth and overcoming resistance to prior therapies.
Primack & Associates, LLC is currently developing the Dynamic Alphabet (DynA) Phonics Reading Software System. DynA utilizes a patented technology to animate and articulate phonic sounds, making it challenging, entertaining, engaging, and fun for children learning to read.
Saneron is a biotechnology R&D company, focused on neurological and cardiac cell therapy for the early intervention and treatment of several devastating or deadly diseases, which lack adequate treatment options.
TransGenex Nanobiotech, Inc. is a Florida-based biotechnology company dedicated to discovering and developing nanoparticle formulations and nano-encapsulation methods for use against novel targets to treat acute and chronic lung diseases and cancers. Current products include Chitosan Nanoparticles, Magnetic Nanoparticles, Hybrid Particles (polymer-magnetic), Functionalized Nanoparticles, and an HIV diagnostic kit.
Trash 2 Cash-Energy has over twenty years of experience in the catalysis industry and is focused on taking landfill gas to liquid fuel. Catalytic production of renewable feedstock to energy is at the heart of our company's interest.
Basking Ridge, N.J
VioQuest Pharmaceuticals, Inc. acquires, develops, and commercializes targeted late preclinical and early clinical stage therapies with unique mechanisms of action for oncology, viral and autoimmune disorders. A pioneer in personalized therapeutics, VioQuest has two targeted therapeutics in clinical trials: VQD-001, an inhibitor of specific protein tyrosine phosphatases, has shown compelling preclinical activity in both renal and melanoma cancers and VQD-002 which has shown to inhibit the phosphorylation of Akt which can be seen in abnormal levels in breast, ovarian, colorectal, pancreatic, and hematologic malignancies.